Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$838 Sell
19
-50
-72% -$2.29K ﹤0.01% 199
2025
Q4
$2.55K Hold
69
﹤0.01% 174
2025
Q3
$2.31K Buy
69
+50
+263% +$1.21K ﹤0.01% 165
2025
Q2
$426 Hold
19
﹤0.01% 177
2025
Q1
$431 Hold
19
﹤0.01% 183
2024
Q4
$381 Hold
19
﹤0.01% 188
2024
Q3
$446 Hold
19
﹤0.01% 208
2024
Q2
$588 Hold
19
﹤0.01% 205
2024
Q1
$839 Hold
19
﹤0.01% 196
2023
Q4
$955 Hold
19
﹤0.01% 195
2023
Q3
$675 Sell
19
-800
-98% -$27.9K ﹤0.01% 232
2023
Q2
$27.4K Buy
819
+654
+396% +$20.5K 0.01% 79
2023
Q1
$5.39K Hold
165
﹤0.01% 128
2022
Q4
$4.36K Hold
165
﹤0.01% 124
2022
Q3
$4K Hold
165
﹤0.01% 121
2022
Q2
$6K Hold
165
﹤0.01% 110
2022
Q1
$8K Hold
165
﹤0.01% 111
2021
Q4
$8K Sell
165
-1,423
-90% -$72.8K ﹤0.01% 97
2021
Q3
$85K Sell
1,588
-207
-12% -$11.2K 0.06% 34
2021
Q2
$101K Sell
1,795
-217
-11% -$12.7K 0.07% 34
2021
Q1
$129K Hold
2,012
0.1% 27
2020
Q4
$100K Hold
2,012
0.07% 28
2020
Q3
$104K Hold
2,012
0.08% 24
2020
Q2
$120K Buy
2,012
+1,610
+400% +$96.3K 0.08% 26
2020
Q1
$22K Buy
+402
New +$23.8K 0.02% 50

Other funds holding INTC

Your Advocates Ltd's INTC Position: Q1 2026 in Review

Your Advocates Ltd reduced its Intel (INTC) stake by 72% in Q1 2026, selling an estimated $2.29K and leaving 19 shares worth $838. The position accounts for ﹤0.01% of the portfolio, ranked #199.

Your Advocates Ltd first reported a position in INTC in Q1 2020 and has held it in 25 quarters since. The position peaked at $129K in Q1 2021. 2,568 funds tracked by Wall St. Rank hold INTC as of Q1 2026.

  • Your Advocates Ltd held 19 shares of Intel worth $838 as of Q1 2026.
  • Your Advocates Ltd sold 50 Intel shares in Q1 2026, an estimated $2.29K.
  • Intel made up ﹤0.01% of Your Advocates Ltd's portfolio in Q1 2026, its #199 holding.
  • Your Advocates Ltd first reported a position in Intel in Q1 2020 and has held it in 25 quarters since.
  • Your Advocates Ltd's Intel position peaked at $129K in Q1 2021.
  • 2,568 funds tracked by Wall St. Rank held Intel as of Q1 2026.

Based on Your Advocates Ltd's 13F filing for Q1 2026, filed 30 Apr 2026.